Nexus AG (0FGL.L)
EUR 68.83
(0.34%)
EUR 68.83
(0.34%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 20.24 Million EUR | 8.43% |
| 2022 | 18.67 Million EUR | 12.27% |
| 2021 | 16.63 Million EUR | 26.43% |
| 2020 | 13.15 Million EUR | 21.07% |
| 2019 | 10.86 Million EUR | 20.72% |
| 2018 | 9 Million EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | -100.0% |
| 2015 | 14 Thousand EUR | -6.67% |
| 2014 | 15 Thousand EUR | -65.12% |
| 2013 | 43 Thousand EUR | -88.83% |
| 2012 | 385 Thousand EUR | -77.45% |
| 2011 | 1.7 Million EUR | -33.01% |
| 2010 | 2.54 Million EUR | -18.96% |
| 2009 | 3.14 Million EUR | 2732.43% |
| 2008 | 111 Thousand EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | -100.0% |
| 2004 | 184 Thousand EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 20.18 Million EUR | -0.31% |
| 2024 Q2 | 20.41 Million EUR | 1.16% |
| 2024 Q3 | 5.02 Million EUR | -0.52% |
| 2023 Q4 | 20.24 Million EUR | 2.55% |
| 2023 Q2 | 20.4 Million EUR | 5.08% |
| 2023 FY | 20.24 Million EUR | 8.43% |
| 2023 Q3 | 19.74 Million EUR | -3.23% |
| 2023 Q1 | 19.41 Million EUR | 3.98% |
| 2022 Q1 | 14.89 Million EUR | -10.44% |
| 2022 Q2 | 17.82 Million EUR | 19.66% |
| 2022 Q3 | 18.39 Million EUR | 3.2% |
| 2022 Q4 | 18.67 Million EUR | 1.51% |
| 2022 FY | 18.67 Million EUR | 12.27% |
| 2021 Q3 | 16.59 Million EUR | -0.22% |
| 2021 FY | 16.63 Million EUR | 26.43% |
| 2021 Q4 | 16.63 Million EUR | 0.21% |
| 2021 Q1 | 13.14 Million EUR | -0.04% |
| 2021 Q2 | 16.63 Million EUR | 26.49% |
| 2020 Q1 | 10.26 Million EUR | -5.53% |
| 2020 Q2 | 8.86 Million EUR | -13.66% |
| 2020 Q3 | 10.94 Million EUR | 23.48% |
| 2020 FY | 13.15 Million EUR | 21.07% |
| 2020 Q4 | 13.15 Million EUR | 20.2% |
| 2019 Q2 | 8.56 Million EUR | -0.56% |
| 2019 Q1 | 8.6 Million EUR | -4.34% |
| 2019 FY | 10.86 Million EUR | 20.72% |
| 2019 Q4 | 10.86 Million EUR | 2.87% |
| 2019 Q3 | 10.56 Million EUR | 23.37% |
| 2018 FY | 9 Million EUR | 0.0% |
| 2018 Q1 | 4.13 Million EUR | 0.0% |
| 2018 Q2 | 4.34 Million EUR | 4.96% |
| 2018 Q3 | 4.6 Million EUR | 6.08% |
| 2018 Q4 | 9 Million EUR | 95.44% |
| 2017 Q1 | 4.66 Million EUR | 0.0% |
| 2017 Q2 | 3.66 Million EUR | -21.45% |
| 2017 Q3 | 3.35 Million EUR | -8.35% |
| 2017 Q4 | - EUR | -100.0% |
| 2017 FY | - EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 Q2 | - EUR | -100.0% |
| 2016 Q1 | 14 Thousand EUR | 0.0% |
| 2016 FY | - EUR | -100.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2015 FY | 14 Thousand EUR | -6.67% |
| 2015 Q3 | 15 Thousand EUR | 0.0% |
| 2015 Q1 | 15 Thousand EUR | 0.0% |
| 2015 Q2 | 15 Thousand EUR | 0.0% |
| 2015 Q4 | 14 Thousand EUR | -6.67% |
| 2014 Q3 | 62 Thousand EUR | 158.33% |
| 2014 Q4 | 15 Thousand EUR | -75.81% |
| 2014 Q2 | 24 Thousand EUR | 0.0% |
| 2014 Q1 | 24 Thousand EUR | -44.19% |
| 2014 FY | 15 Thousand EUR | -65.12% |
| 2013 Q3 | 62 Thousand EUR | -64.57% |
| 2013 Q4 | 43 Thousand EUR | -30.65% |
| 2013 FY | 43 Thousand EUR | -88.83% |
| 2013 Q2 | 175 Thousand EUR | 49.57% |
| 2013 Q1 | 117 Thousand EUR | -69.61% |
| 2012 Q2 | 68 Thousand EUR | 0.0% |
| 2012 Q3 | 2.17 Million EUR | 3100.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 Q4 | 385 Thousand EUR | -82.31% |
| 2012 FY | 385 Thousand EUR | -77.45% |
| 2011 FY | 1.7 Million EUR | -33.01% |
| 2011 Q2 | 2.29 Million EUR | 31.9% |
| 2011 Q1 | 1.74 Million EUR | -31.71% |
| 2011 Q4 | 1.7 Million EUR | -25.62% |
| 2011 Q3 | 2.29 Million EUR | 0.0% |
| 2010 Q2 | 3.2 Million EUR | 32.85% |
| 2010 FY | 2.54 Million EUR | -18.96% |
| 2010 Q4 | 2.54 Million EUR | -3.26% |
| 2010 Q3 | 2.63 Million EUR | -17.87% |
| 2010 Q1 | 2.41 Million EUR | -23.22% |
| 2009 Q4 | 3.14 Million EUR | 0.0% |
| 2009 FY | 3.14 Million EUR | 2732.43% |
| 2008 FY | 111 Thousand EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | -100.0% |
| 2004 FY | 184 Thousand EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cegedim SA | 285.1 Million EUR | 92.899% |
| Guerbet SA | 364.58 Million EUR | 94.447% |
| Bastide Le Confort Médical SA | 356.96 Million EUR | 94.329% |
| Revenio Group Oyj | 18.7 Million EUR | -8.262% |
| Drägerwerk AG & Co. KGaA | 471.38 Million EUR | 95.705% |
| Sartorius Aktiengesellschaft | 5.27 Billion EUR | 99.616% |
| LNA Santé SA | 887.67 Million EUR | 97.719% |
| Siemens Healthineers AG | 633 Million EUR | 96.802% |
| Medios AG | 17.14 Million EUR | -18.06% |
| Equasens Société anonyme | 69.27 Million EUR | 70.775% |
| Stratec SE | 141.37 Million EUR | 85.68% |